Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD

J. Sullivan (Tucson, United States of America), B. Bhagevalu (Tucson, United States of America), L. Sholl (Boston, United States of America), C. Glass (Durham, United States of America), S. Packard (Tucson, United States of America), M. Kraft (Tucson, United States of America), F. Martinez (Tucson, United States of America), J. De Torres (Pamplona, Spain), S. Guerra (Tucson, United States of America), F. Polverino (Tucson, United States of America)

Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Session: Intercellular communication in tissue remodelling of chronic lung diseases
Session type: Oral Presentation
Number: 466
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Sullivan (Tucson, United States of America), B. Bhagevalu (Tucson, United States of America), L. Sholl (Boston, United States of America), C. Glass (Durham, United States of America), S. Packard (Tucson, United States of America), M. Kraft (Tucson, United States of America), F. Martinez (Tucson, United States of America), J. De Torres (Pamplona, Spain), S. Guerra (Tucson, United States of America), F. Polverino (Tucson, United States of America). Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD. 466

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017


Late Breaking Abstract - Effects of tezepelumab on host epithelial tolerance to virus in patients with uncontrolled asthma
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


Adaptive immune system in COPD: auto-immunity or bystander?
Source: Annual Congress 2012 - ERS COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by the Hot Topic "It takes two to tango: innate and adaptive immunity in COPD"
Year: 2012


Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Late Breaking Abstract - Title: Air-born allergens modulate the immunological lung microenvironment.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017

Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Late Breaking Abstract - Formaldehyde inhalation impairs immune system and may affects severity of allergic disease
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Late Breaking Abstract - Enhanced immune activation pathways enriched in patients =70 years with severe COVID-19
Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science
Year: 2021

Late Breaking Abstract - Prediction of chronic lung allograft rejection (CLAD) by measurement of peripheral T cells linked to the inhibitory check-point HLA-G.
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020




Late Breaking Abstract - Disturbance of the core microbiota in transplanted lung associates with sub- or excessive control of host immunity
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019

Late Breaking Abstract - The inflammasome cluster is linked with airway NETosis in COPD
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Determinants of lung cancer evolution: immune escape and inflammation
Source: International Congress 2018 – Scientific Year in Review
Year: 2018


Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations
Source: International Congress 2019 – Airway physiology
Year: 2019


Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Late Breaking Abstract - A comprehensive analysis of endothelial cell markers in pulmonary fibrosis
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014